Literature DB >> 9120729

Demonstration of insulin production and storage in insulinomas by in situ hybridization and immunocytochemistry.

K J McKenzie1, C Hind, M A Farquharson, M McGill, A K Foulis.   

Abstract

Twelve cases of insulinoma were studied to assess the amount of hormone synthesis and hormone storage by the tumour and to see what effect a hormone-producing tumour has on the adjacent normal islets. This was investigated by performing in situ hybridization, which detects hormone messenger RNA, thus giving an indication of the degree of hormone synthesis by the tumour, and immunocytochemistry, which detects the hormone itself, thus giving an indication of the amount of hormone stored in the tumour cells. It was found that in most cases there was less hormone stored within the tumour cells than in adjacent islet cells. In a minority of cases, this decrease in stored hormone was associated with reduced hormone synthesis, but the majority of cases showed either equivalent or increased levels of hormone mRNA in the tumour cells compared with adjacent islets. In addition, it was noted that, unlike some other endocrine organs, the presence of a hormone-producing tumour within the pancreas did not appear to inhibit hormone synthesis in the adjacent normal tissue.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9120729     DOI: 10.1002/(SICI)1096-9896(199702)181:2<218::AID-PATH732>3.0.CO;2-K

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  2 in total

1.  Insulin expressing hepatocytes not destroyed in transgenic NOD mice.

Authors:  Muhammad T Tabiin; Christopher P White; Grant Morahan; Bernard E Tuch
Journal:  J Autoimmune Dis       Date:  2004-11-08

2.  Islet amyloid with macrophage migration correlates with augmented β-cell deficits in type 2 diabetic patients.

Authors:  Kosuke Kamata; Hiroki Mizukami; Wataru Inaba; Kentaro Tsuboi; Yoshinori Tateishi; Taro Yoshida; Soroku Yagihashi
Journal:  Amyloid       Date:  2014-07-09       Impact factor: 7.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.